Global Allergy Immunotherapy Market is estimated to be valued at US$ 2,116.0 million in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Growing approval of immunotherapy by regulatory authority is expected to drive the market growth over the forecast period.
For instance, in 2014, Stallergenes S.A., a healthcare company manufacture the allergy immunotherapy product has received the U.S. Food and Drug Administration approval for ORALAIR(R), for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis.
Click Here for Free Sample Copy (Use corporate email ID Get Higher Priority) @ https://www.coherentmarketinsights.com/insight/request-sample/4915
For instance, in February 2020, Aimmune Therapeutics a biopharmaceutical company, received the U.S. Food and Drug Administration approval for its AR101 (Palforzia) oral peanut-protein immunotherapy for indication of food allergy.
Patients with multiple sensitivities may require a combination of allergens. The concentration of allergens in the mixtures will decrease as more patients are exposed to them. The patient will also benefit from immunotherapy in preventing the onset of asthma in hay fever patients. It is important to consult with a trained allergist to determine the appropriate dosage.
Global Allergy Immunotherapy Market – COVID-19 Impact (Demand and Supply Chain Analysis)
The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors. The private healthcare sector is one such sector which has been majorly impacted by the pandemic.
Moreover, the coronavirus pandemic has negatively impacted the supply of raw materials required for the production of health supplements including brain health supplements, across the globe.
Furthermore, COVID-19 pandemic has affected the economy in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets.
Various manufacturers are facing issues such as shortage of labor and transportation of raw materials, which has affected the production of the immunotherapy. Most of the vehicles used for transportation of these products are stuck at the states borders or at the country’s borders.
Factors such as increasing strategic collaborations and partnerships by key players to expand their presence are expected to drive the global allergy immunotherapy market growth.
For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/4915
For instance, in October 2021, Aptar Pharma, a drug delivery system, service and active material solution provider, entered into partnership with Stallergenes Greer, a healthcare company specializing in allergen immunotherapy, for the development of a new connected drug delivery device and companion mobile app.
Key Takeaways of the Global Allergy Immunotherapy Market:
- The global allergy immunotherapy market is expected to exhibit a CAGR of 3%over the forecast period, owing to increasing prevalence of asthma. For instance, according to the Centers for Disease Control and Prevention (CDC), about 27 million people in the U.S. were suffering from asthma in 2016. Moreover, it is the most common chronic condition among the U.S. children, where one child out of every 12 has asthma.
- Among treatment type, subcutaneous immunotherapy segment is expected to account for the largest market share in 2022, owing to the most commonly used and most effective form of allergy immunotherapy, this is the only treatment for allergy immunotherapy which actually changes the immune system of a patient.
- Key players operating in the global allergy immunotherapy market include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, and Jubilant HollisterStier.
.jpg)
Up-To Avail 30% Discount on various license types on Immediate Purchase @ https://www.coherentmarketinsights.com/promo/buynow/4915
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Treatment Type
- Market Snippet, By Allergy Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launch/Approval
- Epidemiology
- PEST Analysis
- Acquisition And Collaboration Scenario
- Global Allergy Immunotherapy Market – Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- COVID 19 Impact on Supply Chain Analysis
- Global Allergy Immunotherapy Market, By Treatment Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Subcutaneous Immunotherapy (SCIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Sublingual Immunotherapy (SLIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 10-30 MeV
- 30 -70 MeV
- Introduction
- Global Allergy Immunotherapy Market, By Allergy Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Allergic Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Food Allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Venom Allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Global Allergy Immunotherapy Market, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/allergy-immunotherapy-market-4188
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837